A Multicenter, Randomized, Double-blind, Placebo-controlled Phase 3 Study to Evaluate the Safety and Efficacy of ES135 in Subjects With Spinal Cord Injury

Clinical trial NCT03229031 · SUSPENDED

Trial details

NCT number: NCT03229031
Sponsor: Eusol Biotech Co., Ltd.
Status: SUSPENDED
Phase: Phase 3
Study type: INTERVENTIONAL

Spinal Cord Injuries

Start date: 2018-03-07
Primary completion: 2024-12-31
Enrollment: 160

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.